AIRS · CIK 1870940
What AirSculpt Technologies, Inc. told the SEC could break it.
Two single points of failure dominate AirSculpt's register. Every procedure depends on FDA-approved handpieces from one supplier, Euromi, with no long-term supply agreement — an interruption, discontinuation, or demand outstripping Euromi's capacity could halt procedures until an alternative is qualified. And its revenue is geographically concentrated, with five California centers making up 20% of revenue in both 2025 and 2024, tying results to the Southern California economy and California regulation. Layered on top are financial and structural exposures: a Term Loan and revolving facility secured by substantially all of its assets with restrictive covenants, and a corporate-practice-of-medicine model run through affiliated professional associations under management service agreements.
4 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Geographic concentration
- California concentration — five CA centers = 20% of revenuehigh
AirSculpt's five California centers represented 20% of revenue in 2025 and 2024, so disruptions in the Southern California economy (or California regulation) would disproportionately affect its results.
“our five centers located in California represented 20% of our revenue in 2025 and 2024. As a result, our business, financial condition and results of operations could be adversely affected by disruptions in the Southern California economy.”
SEC filing →As of 2026
Sole-source dependency
- single supplier (Euromi) of the FDA-approved handpieces core to AirSculpt procedureshigh
AirSculpt relies on a single supplier, Euromi, for the FDA-approved handpieces essential to its procedures, with no long-term supply agreements; an interruption, Euromi discontinuation, or demand exceeding Euromi's capacity could halt procedures until alternative sources are qualified.
“Our reliance on a single supplier of handpieces subjects us to a number of risks that could harm our business, including: interruption of supply resulting from modifications to or discontinuation of Euromi's operations;”
SEC filing →As of 2026
Liquidity & debt
- Term Loan and Revolving Credit Facility secured by substantially all assets, with restrictive covenantsmedium
AirSculpt's Term Loan and Revolving Credit Facility are secured by substantially all of its assets, carry restrictive covenants (financial ratios, limits on distributions, indebtedness, liens, affiliate transactions) and variable rates; acceleration on a covenant breach could let lenders seize collateral.
“We have pledged substantially all of our assets, excluding assets of our non-guarantor subsidiaries, as security under our Term Loan and Revolving Credit Facility. If the lenders under our Term Loan and Revolving Credit Facility accelerate the repayment of borrowings, we cannot assure you that we will have sufficie”
SEC filing →As of 2026
Regulatory & policy
- corporate-practice-of-medicine (MSA/Professional Association structure) and FDA/healthcare regulationmedium
AirSculpt operates through affiliated Professional Associations under Management Service Agreements to comply with state corporate-practice-of-medicine restrictions, and its procedures use FDA-cleared devices and are subject to healthcare, accreditation and advertising regulation — structural and regulatory risks to its model.
“Due to restrictions on the corporate practice of medicine in many states, the professional associations (each, a “Professional Association,” and collectively, the “Professional Associat”
SEC filing →As of 2026
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings, including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its suppliers
Euromi S.A.
“A supply interruption or an increase in demand beyond Euromi's capabilities could harm our ability to perform AirSculpt ® procedures until new sources of supply are identified and qualified. Our reliance on a single supplier of handpieces subjects us to a number of risks that could harm our business, including: interruption of supply resulting from modifications to or discontinuation of Euromi's operations;”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch